Back to Newsroom
Back to Newsroom

Aphria Continues Expansion, Questions, Catalysts and Hurdles Every Marijuana Stock Investor Should be Considering

Wednesday, 10 April 2019 07:55 AM

NEW YORK, NY / ACCESSWIRE / April 10, 2019 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Aphria, Inc. (NYSE: APHA) produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils.

Traders News Source has created a comprehensive report on the current state of the cannabis market, including an outlook on where the industry may be headed in 2019. Our report discussed the drivers behind the explosive industry growth and the legal issues and hurdles to come in the near term. This report is a must read for investors in cannabis stocks.

Read our comprehensive report on the cannabis/hemp industry here READ MORE

Copy and paste to your browser may be required to view the report - https://tradersnewssource.com/aphria/

On April 5th the company announced that its German subsidiary Aphria Deutschland GmbH ("Aphria Germany") has been selected by the German Federal Institute for Drugs and Medical Devices ("BfArM") to receive a license for the domestic cultivation of medical cannabis.

The company also launched its first CBD-based nutraceutical product on the German market. The product, part of the CannRelief brand, uses hemp-derived CBD and is produced in the European Union.

Read our comprehensive report on the cannabis/hemp industry here READ MORE

Copy and paste to your browser may be required to view the report - https://tradersnewssource.com/aphria/

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://www.tradersnewssource.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

CONTACT: [email protected]

SOURCE: Traders News Source

Topic:
Investor Relations
Back to newsroom
Back to Newsroom
Share by: